Galvin N J, Dixit V M, O'Rourke K M, Santoro S A, Grant G A, Frazier W A
J Cell Biol. 1985 Oct;101(4):1434-41. doi: 10.1083/jcb.101.4.1434.
A panel of monoclonal antibodies (Mab's) has been raised against human platelet thrombospondin (TSP). One Mab, designated A2.5, inhibits the hemagglutinating activity of TSP and immunoprecipitates the NH2 terminal 25 kD heparin binding domain of TSP (Dixit, V.M., D. M. Haverstick, K. M. O'Rourke, S. W. Hennessy, G. A. Grant, S. A. Santoro, and W. A. Frazier, 1985, Biochemistry, in press). Another Mab, C6.7, blocks the thrombin-stimulated aggregation of live platelets and immunoprecipitates an 18-kD fragment distinct from the heparin binding domain (Dixit, V. M., D. M. Haverstick, K. M. O'Rourke, S. W. Hennessy, G. A. Grant, S. A. Santoro, and W. A. Frazier, 1985, Proc. Natl. Acad. Sci. 82: 3472-3476). To determine the relative locations of the epitopes for these Mabs in the three-dimensional structure of TSP, we have examined TSP-Mab complexes by electron microscopy of rotary-shadowed proteins. The TSP molecule is composed of three 180-kD subunits, each of which consists of a small globular domain (approximately 8 nm diam) and a larger globular domain (approximately 16 nm diam) connected by a thin, flexible strand. The subunit interaction site is on the thin connecting strands, nearer the small globular domains. Mab A2.5 binds to the cluster of three small domains, indicating that this region contains the heparin binding domain and thus represents the NH2 termini of the TSP peptide chains. Mab C6.7 binds to the large globular domains on the side opposite the point at which the connecting strand enters the domain, essentially the maximum possible distance from the A2.5 epitope. Using high sensitivity automated NH2 terminal sequencing of TSP chymotryptic peptides we have ordered these fragments within the TSP peptide chain and have confirmed that the epitope for C6.7 in fact lies near the extreme COOH terminus of the peptide chain. In combination with other data, we have been able to construct a map of the linear order of the identified domains of TSP that indicates that to a large extent, the domains are arranged co-linearly with the peptide chain.
已经制备了一组针对人血小板凝血酶敏感蛋白(TSP)的单克隆抗体(Mab)。一种名为A2.5的单克隆抗体可抑制TSP的血凝活性,并免疫沉淀TSP的NH2末端25kD肝素结合结构域(迪克西特,V.M.,D.M.哈弗斯蒂克,K.M.奥罗克,S.W.轩尼诗,G.A.格兰特,S.A.桑托罗,和W.A.弗雷泽,1985年,《生物化学》,即将发表)。另一种单克隆抗体C6.7可阻断凝血酶刺激的活血小板聚集,并免疫沉淀一个与肝素结合结构域不同的18kD片段(迪克西特,V.M.,D.M.哈弗斯蒂克,K.M.奥罗克,S.W.轩尼诗,G.A.格兰特,S.A.桑托罗,和W.A.弗雷泽,1985年,《美国国家科学院院刊》82: 3472 - 3476)。为了确定这些单克隆抗体的表位在TSP三维结构中的相对位置,我们通过旋转阴影蛋白的电子显微镜检查了TSP - Mab复合物。TSP分子由三个180kD的亚基组成,每个亚基由一个小球形结构域(直径约8nm)和一个大球形结构域(直径约16nm)通过一条细的柔性链连接而成。亚基相互作用位点在细连接链上,更靠近小球形结构域。单克隆抗体A2.5与三个小结构域的簇结合,表明该区域包含肝素结合结构域,因此代表TSP肽链的NH2末端。单克隆抗体C6.7与连接链进入结构域的点相对侧的大球形结构域结合,基本上是与A2.5表位的最大可能距离。使用TSP胰凝乳蛋白酶肽段的高灵敏度自动NH2末端测序,我们已将这些片段在TSP肽链中排序,并证实C6.7的表位实际上位于肽链的极端COOH末端附近。结合其他数据,我们能够构建TSP已鉴定结构域的线性顺序图谱,表明在很大程度上,这些结构域与肽链共线排列。